Final programme
COMPARATIVE PHYSIOPATHOLOGY - species differences, do they matter?
10am/5pm
Choice of animal species for regulatory toxicology in pharmaceutical development
Jayne Harris, AstraZeneca
​
Use of preclinical species to inform human pharmacokinetics in drug development
Christina Chan, AstraZeneca
​​​
The immune system: friend or foe in model selection?
Richard Haworth, RosettaPath
​​
Target organ toxicity in non-clinical toxicology studies: Urinary system and Eye - relevance to humans?
Naylor Stuart, Charles River Laboratories
​
Target organ toxicity in non-clinical toxicology studies; relevance to humans?
Jacobsen Matthew, AstraZeneca